Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05003063 · ClinicalTrials.gov registry record · Early Phase 1

Effects of Acetylcholine and Attention on Visual Spatial Representations in the Brain

A Early Phase 1 study of Attention and Visual Perception, sponsored by University of California, Berkeley.

Completed
Registry status
Early Phase 1
Development phase
12
Enrollment target
1
Study location

NCT05003063 is a Early Phase 1 study of Attention and Visual Perception that has completed, run by University of California, Berkeley. The registered enrollment target is 12 participants, below the 96-participant average among 13 other Attention trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05003063, a Early Phase 1 study of Attention and Visual Perception, has completed, sponsored by University of California, Berkeley.

COMPLETED
Registry status
Early Phase 1
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This study in, healthy human subjects using fMRI and MRS (magnetic resonance spectroscopy) characterizes, how attention and acetylcholine affect visual perception and the brain's representation of the visual environment. Levels of acetylcholine in the cerebral cortex will be enhanced by administration of donepezil, an inhibitor of acetylcholinesterase. Half the subjects will receive donepezil and other half will receive placebo.

Interventions

  • DRUG Placebo oral tablet
  • DRUG Donepzil

Study Locations (1)

California

  • University of California, Berkeley - Berkeley

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-02-04
Est. Completion 2021-08-02
Phase Early Phase 1

Sponsor

University of California, Berkeley

72 total trials

What the Registry Record Tells You About NCT05003063

The ClinicalTrials.gov registry entry for NCT05003063 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 13 other Attention trials with a reported enrollment target (87% lower). The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Attention appearing as the primary indexed condition, and to 2 interventions - of which Placebo oral tablet is the first listed.

NCT05003063 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05003063 about?

NCT05003063 is a clinical study titled "Effects of Acetylcholine and Attention on Visual Spatial Representations in the Brain". This study in, healthy human subjects using fMRI and MRS (magnetic resonance spectroscopy) characterizes, how attention and acetylcholine affect visual perception and the brain's representation of the visual environment. Levels of acetylcholine in the cerebral cortex will be enhanced by administrati...

What is the current status of trial NCT05003063?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 12 participants. The study started on 2021-02-04. Estimated completion is 2021-08-02.

What conditions does trial NCT05003063 study?

This clinical trial studies the following conditions: Attention, Visual Perception, Information Processing, Cholinergic System.

What interventions are being tested in trial NCT05003063?

The interventions under investigation include: Placebo oral tablet (DRUG), Donepzil (DRUG).

Who is sponsoring clinical trial NCT05003063?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05003063 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.